Warren Point Capital

Warren Point Capital is a U.S.-focused venture capital firm specializing in life sciences, biotechnology and medical devices, with additional exposure to health technology and oncology. It backs companies across early and later-stage venture opportunities, targeting critical value inflection points such as preclinical, clinical, regulatory, IP or commercial risk reduction. The firm can act as lead investor or participate in syndicates in larger rounds and co-invests its own risk capital alongside fund investors.